Health care stocks declined Tuesday afternoon, with the NYSE Health Care Index falling 2.1% and the Health Care Select Sector SPDR Fund (XLV) dropping 2.8%.
The iShares Biotechnology ETF (IBB) slumped 6%.
In corporate news, Beam Therapeutics (BEAM) shares tumbled past 17% after it reported a wider Q1 loss compared with a year earlier.
Philips (PHG) shares fell 5.5% after it reported flat Q1 adjusted earnings per share, while sales declined.
Viridian Therapeutics (VRDN) shares were down 7.4% after it reported a Q1 net loss of $0.87 per diluted share, widening from a loss of $0.59 a year earlier.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。